| Medgenics Inc. is an early stage American/Israeli biotechnology company developing a method to revolutionize protein therapy. Its unique platform technology, Biopump, was patented by a leading Israeli research center and exclusively licensed to Medgenics through its wholly owned Israeli subsidiary and R & D Center, Biogenics Ltd. Managed and driven by a highly experienced team in biotechnology and biomedical device development , Medgenics is backed by top biotech venture capital funds from the USA, Europe and Israel. Its Board of Directors and Scientific Advisory Board include some of the pioneers who built the Biotechnology industry, and premier leaders from the Pharma industry and academia. |
